This suppression, linked to RORα-mediated decrease in pyruvate dehydrogenase kinase 2 expression, inhibits hepatoma growth through mechanisms involving the upregulation of p21, as observed in both in vitro and in vivo models [70]. The gene discussed is RORA; the disease is hepatocellular carcinoma.